Leaflet AMARYL 1mg tablets

Product code:
W62433005
Quantity:
30
Indicated for:
type 2 diabetes mellitus
Route of administration:
oral
Substance:
glimepiride (sulfonylurea antidiabetic)
ATC
A10BB12 — Alimentary tract and metabolism | Blood glucose lowering drugs, excl. insulins | Sulfonylureas

Precautions:

Hypoglycemia

Hypoglycemia

This medicine may lower blood sugar.

Glimepiride is an antidiabetic medication from the sulfonylurea class, used to control blood sugar levels in patients with type 2 diabetes. It works by stimulating the pancreas to produce more insulin and improving the sensitivity of cells to insulin, thereby helping to lower blood sugar levels.

It is recommended as part of a treatment plan that includes a balanced diet, regular physical activity, and blood sugar monitoring. Glimepiride is effective in preventing diabetes-related complications, such as damage to small blood vessels (retinopathy, nephropathy).

Side effects may include hypoglycemia (excessive drop in blood sugar), nausea, dizziness, weight gain, or allergic reactions. It is important for patients to follow the prescribed dosage and watch for signs of hypoglycemia, such as shaking, sweating, or confusion.

General data about AMARYL 1mg

Substance:
glimepiride
Date of latest medicines list:
01-06-2026
Product code:
W62433005
Concentration:
1mg
Pharmaceutical form:
tablets
Quantity:
30
Product type:
Original
Price:
6.69 RON
Prescription status:
P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.

Marketing authorisation

Manufacturer:
SANOFI - AVENTIS S.P.A. - ITALIA
Holder:
SANOFI ROMANIA S.R.L. - ROMANIA
Number:
2415/2010/05
Shelf life:
3 years

Concentrations available for glimepiride

  • 1mg
  • 2mg
  • 3mg
  • 4mg
  • 6mg

Compensation lists for AMARYL 1mg Sanofi

NHP 5 (C2) - Diabetes

Price
6.69 RON
Copayment
6.69 RON
Patient
0.00 RON